L.A. County + U.S.C. Medical Center
Los Angeles, California, 90033, United States
NCT Number: NCT01291277
Patients with liver disease frequently present to the hospital with bleeding from dilated veins in their foodpipe (called esophageal varices). The current standard of care is to perform endoscopic variceal ligation (placing rubber bands around the varices through an endoscope)in patients presenting with bleeding varices. Patients generally receive ligation at the time they come in with bleeding and then return at regular intervals to have repeat ligation in order to eradicate the varices. However there have been no studies to determine the appropriate intervals for esophageal variceal ligation until eradication. We will conduct a randomized comparison of 1-week vs. 2-week intervals for esophageal ligation in patients that have presented with bleeding varices. Our hypothesis is that one-week ligation will achieve more rapid eradication than the two-week interval with a greater proportion of patients achieving variceal eradication at 4 weeks after the index bleeding episode.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Los Angeles, California, 90033, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ligation of esophageal varices
Other names: variceal banding
Time frame: At 4 weeks
University of Southern California
Other
Appropriate Time Interval for Repeat Sessions of Endoscopic Ligation for the Eradication of Esophageal Varices
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06839352
Digestive System Diseases, Esophageal Diseases
Zagazig, Sharqia Province, Egypt
View Trial DetailsNCT07106658
Cirrhosis, Digestive System Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT00570973
Brain Diseases, Central Nervous System Diseases
Linz, Upper Austria, Austria
View Trial DetailsNCT07571876
Chronic Liver Disease (CLD), Digestive System Diseases
View Trial Details